| # | Drug | Count |
|---|---|---|
| 0 | COPPER | 266 |
| 1 | LEVONORGESTREL | 227 |
| 2 | METRONIDAZOLE | 92 |
| 3 | ERGOCALCIFEROL | 88 |
| 4 | ACETAMINOPHEN | 82 |
| 5 | METHOTREXATE SODIUM | 65 |
| 6 | METHOTREXATE | 62 |
| 7 | ADALIMUMAB | 60 |
| 8 | PREDNISONE | 60 |
| 9 | ESTRADIOL | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROMETHORPHAN HBR AND PYRILAMINE MALEATE | 2 | 0.1176 |
| 1 | METRONIDAZOLE VAGINAL GEL, 1.3 % | 3 | 0.1154 |
| 2 | PIPER METHYSTICUM ROOT | 1 | 0.0435 |
| 3 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL | 1 | 0.0357 |
| 4 | SECNIDAZOLE | 10 | 0.0355 |
| 5 | BORIC ACID | 4 | 0.0113 |
| 6 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 2 | 0.0110 |
| 7 | PROTRIPTYLINE HYDROCHLORIDE | 1 | 0.0104 |
| 8 | INFLIXIMAB-DYYB | 35 | 0.0102 |
| 9 | TELMISARTAN AND AMLODIPINE | 1 | 0.0100 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 316 |
| 1 | Copper-containing Intrauterine Device [EPC] | 269 |
| 2 | Progestin-containing Intrauterine System [EPC] | 227 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 166 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 141 |
| 5 | Estrogen [EPC] | 135 |
| 6 | Corticosteroid [EPC] | 109 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 103 |
| 8 | Provitamin D2 Compound [EPC] | 88 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 80 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 269 | 0.0054 |
| 1 | Provitamin D2 Compound [EPC] | 88 | 0.0030 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 3 | Estrogen Agonist/Antagonist [EPC] | 5 | 0.0019 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 103 | 0.0016 |
| 5 | Interleukin-17A Antagonist [EPC] | 48 | 0.0013 |
| 6 | Human Immunoglobulin G [EPC] | 24 | 0.0011 |
| 7 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 8 | Progestin [EPC] | 316 | 0.0011 |
| 9 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |